{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:10:31Z","timestamp":1781010631489,"version":"3.54.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The misuse of opioids has increased significantly in recent decades. Historically, cancer patients have not been considered at risk of opioid misuse. However, cancer pain is common, and opioids are often prescribed. Guidelines addressing opioid misuse often exclude cancer patients. Given that misuse is associated with significant harm and a reduction in quality of life, it is important to understand the risk of opioid misuse in cancer patients and how we can recognise and treat it.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Early cancer diagnoses and treatments have improved cancer survival rates, leading to a larger population of cancer patients and survivors. Opioid use disorder (OUD) may precede a cancer diagnosis or may develop during or after treatment. The effect of OUD extends from an individual patient to a societal level. This review examines the increasing incidence of OUD in cancer patients, ways to identify patients with OUD such as behaviour change and screening scales, prevention of OUD such as limited and targeted opioid prescriptions, and evidence-based treatment suggestions for OUD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>OUD in cancer patients has only relatively recently been recognised as a growing problem. Early identification, involvement of the multidisciplinary team, and treatment can reduce the negative impact of OUD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000640","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T10:04:30Z","timestamp":1677837870000},"page":"98-103","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Opioid use disorder in cancer patients"],"prefix":"10.1097","volume":"17","author":[{"given":"Cara E.S.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5815-3857","authenticated-orcid":false,"given":"John","family":"Schutzer-Weissmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Farquhar-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/14740338.2019.1579796","article-title":"Potential strategies to combat the opioid crisis","volume":"18","author":"Mercadante","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"R2-20250525","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3959(86)90091-6","article-title":"Chronic use of opioid analgesics in non-malignant pain: report of 38 cases","volume":"25","author":"Portenoy","year":"1986","journal-title":"Pain"},{"key":"R3-20250525","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/ADM.0000000000000711","article-title":"Cannabinoids for the treatment of opioid use disorder: where is the evidence","volume":"15","author":"Suzuki","year":"2021","journal-title":"J Addict Med"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.15585\/mmwr.mm6449a1","article-title":"Invasive cancer incidence and survival \u2013 United States, 2012","volume":"64","author":"Henley","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-20250525","first-page":"CD012637","article-title":"Oral paracetamol (acetaminophen) for cancer pain","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain \u2013 United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3390\/jcm11061594","article-title":"Prevalence of opioid use disorder among patients with cancer-related pain: a systematic review","volume":"11","author":"Preux","year":"2022","journal-title":"J Clin Med"},{"key":"R11-20250525","first-page":"535","article-title":"Cancer pain and opioid use disorder","volume":"36","author":"Ganguly","year":"2022","journal-title":"Oncology"},{"key":"R13-20250525","doi-asserted-by":"crossref","first-page":"208216","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: a review","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"R14-20250525","first-page":"71","article-title":"Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review","volume":"7","author":"Carmichael","year":"2016","journal-title":"Subst Abuse Rehabil"},{"key":"R15-20250525","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1634\/theoncologist.2019-0540","article-title":"Best practices in the management of nonmedical opioid use in patients with cancer-related pain","volume":"25","author":"Ulker","year":"2020","journal-title":"Oncologist"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"e2013605","DOI":"10.1001\/jamanetworkopen.2020.13605","article-title":"National patterns in prescription opioid use and misuse among cancer survivors in the United States","volume":"3","author":"Jairam","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R18-20250525","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"R19-20250525","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jamaoncol.2020.6789","article-title":"Frequency of and factors associated with nonmedical opioid use behaviour among patients with cancer receiving opioids for cancer pain","volume":"7","author":"Yennurajalingam","year":"2021","journal-title":"JAMA Oncol"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1200\/JCO.2014.56.0383","article-title":"Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer","volume":"32","author":"Greco","year":"2014","journal-title":"J Clin Oncol"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1200\/JOP.2017.024901","article-title":"Opioid prescription trends among patients with cancer referred to outpatient palliative care over a 6-year period","volume":"13","author":"Haider","year":"2017","journal-title":"J Oncol Pract"},{"key":"R23-20250525","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/cncr.30839","article-title":"Cancer survivorship and opioid prescribing rates: a population-based matched cohort study among individuals with and without a history of cancer","volume":"123","author":"Sutradhar","year":"2017","journal-title":"Cancer"},{"key":"R24-20250525","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jamaoncol.2019.1439","article-title":"Prevalence of chronic pain and high-impact chronic pain in cancer survivors in the United States","volume":"5","author":"Jiang","year":"2019","journal-title":"JAMA Oncol"},{"key":"R25-20250525","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/jnci\/djz233","article-title":"Emergency department visits for opioid overdoses among patients with cancer","volume":"112","author":"Jairam","year":"2020","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R28-20250525","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjmed.2016.08.041","article-title":"Managing increasing liability risks related to opioid prescribing","volume":"130","author":"Yang","year":"2017","journal-title":"Am J Med"},{"key":"R29-20250525","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u22122015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R30-20250525","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain \u2013 United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"R31-20250525","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/NJH.0000000000000384","article-title":"Justice in America: ethical issues in cancer pain control","volume":"19","author":"Paice","year":"2017","journal-title":"J Hosp Palliat Nurs"},{"key":"R33-20250525","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jpainsymman.2020.06.015","article-title":"Cancer patients\u2019 perceived difficulties filling opioid prescriptions after receiving outpatient supportive care","volume":"60","author":"Brown","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"R34-20250525","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.21.00476","article-title":"US trends in opioid access among patients with poor prognosis cancer near the end-of-life","volume":"39","author":"Enzinger","year":"2021","journal-title":"J Clin Oncol"},{"key":"R35-20250525","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1016\/j.jpainsymman.2021.05.002","article-title":"Compassion inequities and opioid use disorder: a matched case-control analysis examining inpaitent management of cancer-related pain for patients with opioid use disorder","volume":"62","author":"Singh","year":"2021","journal-title":"J Pain Symptom Manag"},{"key":"R36-20250525","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"R37-20250525","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-244X-11-150","article-title":"Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine","volume":"11","author":"Schneider","year":"2011","journal-title":"BMC Psychiatry"},{"key":"R38-20250525","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpain.2007.11.014","article-title":"Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R)","volume":"9","author":"Butler","year":"2008","journal-title":"J Pain"},{"key":"R39-20250525","doi-asserted-by":"crossref","first-page":"e19306","DOI":"10.1097\/MD.0000000000019306","article-title":"The impact of pain and opioids use on survival in cancer patients: results from a population-based cohort study and a meta-analysis","volume":"99","author":"Zheng","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R40-20250525","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/NJH.0000000000000828","article-title":"When management of cancer-related pain is complicated by coexisting opioid use disorder: a case review","volume":"24","author":"Lowry","year":"2022","journal-title":"J Hosp Palliat Nurse"},{"key":"R41-20250525","first-page":"26","article-title":"Harder to treat than leukaemia \u2013 opioid use disorder in survivors of cancer","volume":"379","author":"Wakoff Loren","year":"2018","journal-title":"NEJM"},{"key":"R42-20250525","doi-asserted-by":"crossref","first-page":"691720","DOI":"10.3389\/fpain.2021.691720","article-title":"Opioid therapy in cancer patients and survivors at risk of addiction, misuse or complex dependency","volume":"2","author":"Pergolizzi","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"key":"R43-20250525","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/theoncologist.2016-0266","article-title":"The impact of an educational program on patient practices for safe use, storage, and disposal of opioids at a comprehensive cancer center","volume":"22","author":"de la Cruz","year":"2017","journal-title":"Oncologist"},{"key":"R44-20250525","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.029","article-title":"Opioid-induced hyperalgesia: cellular and molecular mechanisms","volume":"338","author":"Roeckel","year":"2016","journal-title":"Neuroscience"},{"key":"R45-20250525","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","article-title":"Harm reduction principles for healthcare settings","volume":"14","author":"Hawk","year":"2017","journal-title":"Harm Reduct J"},{"key":"R46-20250525","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol"},{"key":"R47-20250525","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/j.pain.0000000000002265","article-title":"International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement","volume":"162","year":"2021","journal-title":"Pain"},{"key":"R48-20250525","doi-asserted-by":"crossref","first-page":"e2139968","DOI":"10.1001\/jamanetworkopen.2021.39968","article-title":"Expert panel consensus on management of advanced cancer-related pain in individuals with opioid use disorder","volume":"4","author":"Merlin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R49-20250525","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.2017-0248","article-title":"Outcomes of a specialized interdisciplinary approach for patients with cancer with aberrant opioid-related behavior","volume":"23","author":"Arthur","year":"2018","journal-title":"Oncologist"},{"key":"R50-20250525","doi-asserted-by":"crossref","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Swarm","year":"2019","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T18:01:07Z","timestamp":1748196067000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000640","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,3]]}}}